Granulomatous amoebic encephalitis

Editor-In-Chief: Prab R Tumpati, MD
Obesity, Sleep & Internal medicine
Founder, WikiMD Wellnesspedia &
W8MD's weight loss doctor NYC
Philadelphia GLP-1 weight loss and GLP-1 clinic NYC
| Granulomatous amoebic encephalitis | |
|---|---|
| |
| Synonyms | N/A |
| Pronounce | N/A |
| Specialty | N/A |
| Symptoms | Headache, fever, nausea, vomiting, neurological deficits |
| Complications | Seizures, coma, death |
| Onset | Gradual |
| Duration | Progressive |
| Types | N/A |
| Causes | Acanthamoeba, Balamuthia mandrillaris, Sappinia diploidea |
| Risks | Immunocompromised state, HIV/AIDS, organ transplantation |
| Diagnosis | Brain biopsy, MRI, CT scan, CSF analysis |
| Differential diagnosis | Bacterial meningitis, viral encephalitis, brain abscess |
| Prevention | N/A |
| Treatment | Antimicrobial therapy, surgical intervention |
| Medication | N/A |
| Prognosis | Poor |
| Frequency | Rare |
| Deaths | N/A |
Granulomatous Amoebic Encephalitis (GAE) is a rare, often fatal, central nervous system infection caused by certain amoebic species, primarily Acanthamoeba spp., and less frequently by Balamuthia mandrillaris. This condition is characterized by the formation of granulomas, which are inflammatory lesions, in the brain and spinal cord. GAE typically occurs in individuals with compromised immune systems but can also affect healthy persons.
Causes and Transmission[edit]
GAE is caused by amoebae, microscopic single-celled organisms, which are commonly found in soil, freshwater, and other environments. The primary amoebae responsible for GAE are:
These amoebae can enter the human body through various routes, such as inhalation of dust containing the amoebae, contamination of skin wounds, or through the nasal passages and eyes. Once inside the body, the amoebae can travel to the central nervous system, leading to GAE.
Symptoms[edit]
The symptoms of GAE can vary but often include:
- Headache
- Fever
- Stiff neck
- Nausea and vomiting
- Confusion
- Loss of coordination
- Seizures
- Coma
Symptoms can progress rapidly, and the disease can be fatal if not treated promptly.
Diagnosis[edit]
Diagnosing GAE involves a combination of clinical evaluation, imaging studies, and laboratory tests. Methods used in the diagnosis include:
- Magnetic Resonance Imaging (MRI) or Computed Tomography (CT) Scan to detect lesions in the brain.
- Lumbar puncture to analyze cerebrospinal fluid.
- Biopsy of brain tissue.
- Polymerase Chain Reaction (PCR) testing to identify amoebic DNA.
Treatment[edit]
Treatment of GAE is challenging and often involves a combination of antimicrobial agents. The most commonly used medications include:
- Amphotericin B
- Fluconazole or Itraconazole
- Rifampicin
- Sulfadiazine
Early diagnosis and aggressive treatment are crucial for improving outcomes, as the disease progresses rapidly and is often fatal.
Prevention[edit]
Preventive measures for GAE are primarily aimed at reducing exposure to the amoebae. Recommendations include:
- Avoiding contact with soil and freshwater sources that may be contaminated.
- Using sterile or distilled water for nasal irrigation.
- Properly cleaning and disinfecting contact lenses.
- Covering skin wounds when in environments where exposure to soil or water is likely.
Epidemiology[edit]
GAE is a rare disease, with cases reported worldwide. It primarily affects individuals with compromised immune systems but can also occur in healthy persons. The exact incidence and prevalence of the disease are unknown due to its rarity and the challenges associated with diagnosis.
See Also[edit]
- Amoebic Meningoencephalitis
- Acanthamoeba Keratitis
- Balamuthia Amoebic Encephalitis
- Naegleria fowleri
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
